🔎 Trials Near Me

Utama › Hemofilia › Michigan

Kajian klinikal Hemofilia di Michigan

5 kajian untuk Hemofilia sedang mencari peserta di lokasi di Michigan.

Bandar di Michigan

Teks kajian rasmi (Bahasa Inggeris)

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  • Central Michigan Children's Hospital of Michigan, Detroit
  • Henry Ford Health System Bleeding and Thrombosis Treatment Center, Detroit
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT04398628

Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis

  • Children's Hospital of Michigan, Detroit
Mengambil pesertaKajian pemerhatian
Umur 6 hingga 19 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT05022459

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)

  • University of Michigan Hospitals - Michigan Medicine, Ann Arbor
Mengambil pesertaFasa 1Sukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 2 Jul 2026 · NCT06349473

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  • University of Michigan Medical School, Ann Arbor
  • Central Michigan University: Children's Hospital of Michigan, Mount Pleasant
Mengambil pesertaFasa 1
Umur 0 hingga 90 · Semua jantina · Dikemas kini 3 Apr 2026 · NCT05500807

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

  • Children's Hospital of Michigan, Detroit
  • Henry Ford Health System, Detroit
  • MSU Center for Bleeding and Clotting Disorders, Lansing
Mengambil pesertaFasa 4
Umur 12 hingga 100 · Semua jantina · Dikemas kini 12 Jan 2026 · NCT04647227

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.